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Amyotrophic Lateral Sclerosis (ALS) is an invariably fatal neurodegenerative disorder,
which specifically targets motor neurons in the brain, brain stem and spinal cord.
Whilst the etiology of ALS remains unknown, fragmentation of the Golgi apparatus
is detected in ALS patient motor neurons and in animal/cellular disease models.
The Golgi is a highly dynamic organelle that acts as a dispatching station for the
vesicular transport of secretory/transmembrane proteins. It also mediates autophagy
and maintains endoplasmic reticulum (ER) and axonal homeostasis. Both the trigger for
Golgi fragmentation and the functional consequences of a fragmented Golgi apparatus
in ALS remain unclear. However, recent evidence has highlighted defects in vesicular
trafficking as a pathogenic mechanism in ALS. This review summarizes the evidence
describing Golgi fragmentation in ALS, with possible links to other disease processes
including cellular trafficking, ER stress, defective autophagy, and axonal degeneration.
Keywords: amyotrophic lateral sclerosis, Golgi fragmentation, ER stress, axonal degeneration, secretory
trafficking inhibition, autophagy dysfunction
INTRODUCTION
The Golgi apparatus (referred to as “Golgi” hereafter) acts as a dispatching station whereby proteins
and lipids newly synthesized in the ER are transported to the endosomal system, secretory granules,
or plasma membrane. In spite of being a highly dynamic organelle (Griffiths et al., 1989), the Golgi
normally maintains a characteristic morphology, consisting of flattened membrane stacks known
as cisternae, and associated vesicles. The stacks of Golgi cisternae are interconnected laterally by
tubules, forming a ribbon-like network (Rambourg and Clermont, 1990; Polishchuk and Mironov,
2004), usually in the perinuclear region of the cell, adjacent to the centrosome (Linstedt, 2004).
The Golgi comprises of three functional compartments: the cis-Golgi, which being the nearest
compartment to the ER, forms the entry face to the Golgi, the medial-Golgi, which is responsible
for the modification, sorting and packaging of proteins for transportation, and finally the trans
Golgi network, which forms the exit face of the Golgi (Rothman and Wieland, 1996; Glick and
Nakano, 2009). Specific types of intracellular vesicles are associated with the Golgi. Secretory
protein cargo buds from the ER via coat protein complex II (COPII) coated vesicles, to form
tubulovesicular structures known as the ER-Golgi intermediate compartment (ERGIC), which
eventually fuse with the cis-Golgi (Appenzeller-Herzog and Hauri, 2006). In contrast, the reticular
trans-Golgi network (TGN) produces clathrin-coated vesicles which are targeted to endosomes
and secretory vesicles in specialized cell types such as neurons (De Matteis and Luini, 2008).
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In addition to secretory trafficking, the Golgi is also responsible
for the post-translational modification of proteins and lipids,
including glycosylation (Stanley, 2011), sulfation (Baeuerle and
Huttner, 1987), and proteolytic cleavage (Xu and Shields, 1993).
THE GOLGI IN NEURONS
Neurons are highly specialized cells with unique functional
and morphological characteristics. Interestingly, in neurons the
Golgi forms specialized “Golgi outposts” localized in axons and
dendrites, which are discrete structures that are discontinuous
from the somatic Golgi (Figure 1). These Golgi outposts are not
fully characterized, but are thought to facilitate local secretory
trafficking within neurites (Horton and Ehlers, 2003; Merianda
et al., 2009). Axonal transport is an important property in
neurons which involves trafficking of cellular proteins and
vesicles within the axon, towards or away from the cell body.
The relationship between axonal transport and transport within
the soma is not fully understood, but these processes are clearly
linked and involve the Golgi (Hirokawa and Takemura, 2005;
Schwarz, 2013).
FRAGMENTATION OF THE GOLGI
APPARATUS
The Golgi is capable of undergoing profound morphological
changes during normal cellular processes such as mitosis,
as well as in pathological conditions. These morphological
changes result in disruption of its characteristic ribbon-like
network, forming a fragmented Golgi. Golgi fragmentation
during mitosis facilitates equal distribution of the Golgi
into the resulting daughter cells (Sütterlin et al., 2002).
However, irreversible Golgi fragmentation occurs in pathological
situations, when apoptosis is activated. Under these conditions,
structural proteins within the Golgi are cleaved by the action
of caspases (Lane et al., 2002). The Golgi also fragments
when vesicular secretory trafficking is perturbed (Dascher and
Balch, 1994; Wilson et al., 1994), which may also occur in
pathological conditions. The morphological changes evident
during fragmentation of the Golgi are attributed to two
possibilities, either the Golgi membranes break into smaller
dispersed vesicular structures (Figure 1), or the Golgi fuses with
the ER upon fragmentation, which is then recycled, and it
remerges at ER exit sites, dispersed throughout the cytoplasm
(Cole et al., 1996; Storrie et al., 1998; Pelletier et al., 2000; Glick,
2002).
Golgi pathology is a feature of neurodegenerative diseases
including Alzheimer’s disease (Sun et al., 2008), Parkinson’s
disease (Fujita et al., 2006), Creutzfeldt-Jakob disease (Sakurai
et al., 2000), multiple system atrophy (Sakurai et al., 2002),
and ALS. Interestingly, Golgi fragmentation is often detected
as an early event in these conditions, prior to apoptosis
(Gosavi et al., 2002; Liazoghli et al., 2005; Atkin et al., 2014;
van Dis et al., 2014), suggesting that Golgi fragmentation
could be a trigger for neurodegeneration rather than a
simple consequence of neuronal death. We review here
the evidence describing Golgi fragmentation in ALS, and
discuss recent studies implicating impairment of ER-Golgi
mediated vesicular trafficking as a possible trigger. We
also predict possible downstream consequences of Golgi
fragmentation in ALS, and we examine links to other pathologies,
including ER stress, autophagy dysfunction, and axonal
degeneration.
AMYOTROPHIC LATERAL SCLEROSIS
Whilst 90% of ALS cases are sporadic, 10% of cases are familial,
caused by mutations in genes encoding ubiquitously expressed
proteins, including transactive response DNA binding protein
(TDP-43), fused in sarcoma (FUS), optineurin, superoxide
dismutase 1 (SOD1), and Chromosome 9 open reading frame 72
(C9orf72) (Renton et al., 2014) (Table 1). Although, the etiology
of ALS remains unknown, RNA dysfunction and disruption to
proteostasis are widely implicated as pathogenic mechanisms
(Ling et al., 2013). Dysfunction to proteostasis includes protein
misfolding and aggregation, ER stress, Golgi fragmentation,
autophagy dysfunction, inhibition of cellular trafficking, and
axonal degeneration. Like other neurodegenerative disorders, a
pathological hallmark of ALS is the accumulation of intracellular
inclusions containing misfolded protein aggregates (Wood
et al., 2003; Blokhuis et al., 2013). Interestingly, wildtype
(WT) forms of TDP-43, FUS, optineurin, and SOD1 may be
recruited into ubiquitinated protein inclusions in sporadic ALS
patients (Neumann et al., 2006; Deng et al., 2010; Blokhuis
et al., 2013). Cytoplasmic accumulation, hyperphosphorylation
and/or aggregation of TDP-43 is present in almost all cases
of ALS (approximately 97%) (Ling et al., 2013). Transgenic
mice overexpressing mutant SOD1G93A are the most widely
used animal models of disease, which recapitulate many
clinical and pathological features of ALS (Gurney et al., 1994).
Increasing evidence now links ALS to frontotemporal dementia
(FTD), with recent studies suggesting that ALS and FTD
represent opposite ends of the disease spectrum (Ling et al.,
2013).
Defects in intracellular trafficking, particularly within the
axon, are implicated in ALS (Bilsland et al., 2010; Ikenaka
et al., 2012; Alami et al., 2014). The “dying back” or slow
degeneration of distal to proximal axons is associated with
loss of motor neurons in ALS (Fischer et al., 2004; Dadon-
Nachum et al., 2011; Moloney et al., 2014). In SOD1 mice, distal
axonopathy and denervation of neuromuscular junctions are
observed prior to the onset of clinical manifestations (Fischer
et al., 2004). Fast-fatigable motor neurons with the longest axons
and highest metabolic demands, are the most susceptible to
axonal degeneration (Frey et al., 2000; Fischer et al., 2004). It has
been suggested that lack of supply of essential proteins and lipids
to distal axons is associated with axonal degeneration (Perlson
et al., 2010).
Autophagy is an important proteostatic mechanism to
degrade misfolded proteins in post-mitotic neurons (Thomas
et al., 2013). It is therefore not surprising that defects in
autophagy are present in ALS, however the nature of autophagy
defects in ALS remains unclear. Autophagosomes accumulate
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FIGURE 1 | Illustration of Golgi functions in a healthy neuron, and Golgi fragmentation in an ALS-affected neuron. The Golgi in a healthy neuron regulates
vesicular trafficking from the ER to the plasma membrane. The Golgi is also involved in the biogenesis of autophagosomes and lysosomes. Golgi outposts in healthy
axons are involved in local synthesis and trafficking of axonal membrane proteins. Golgi fragmentation in ALS may be triggered by pathogenic mutant proteins that
inhibit vesicular trafficking between the ER-Golgi, and Golgi to plasma membrane. Possible consequences of Golgi fragmentation in ALS include autophagy
dysfunction, impaired axonal secretory trafficking, and loss of axonal homeostasis.
in ALS patient brain tissues (Sasaki, 2011), implying that
both induction of autophagy and inhibition of clearance of
autophagsomes exist in ALS. However, more recent studies
have demonstrated that formation of the autophagosome is
impaired in cells expressing ALS mutant FUS (Soo et al.,
2015b) and in cells with reduced C9orf72 expression (Farg
et al., 2014). Furthermore, mutations in proteins involved in
endosomal sorting and trafficking which are required for the
formation of autophagosomes (VCP, p62, dynactin, and RAB7)
are also associated with ALS (Otomo et al., 2012). Activation
of the unfolded protein response (UPR) and ER stress are well-
documented pathogenic features in human ALS patients (Ilieva
et al., 2007; Atkin et al., 2008; Oyanagi et al., 2008; Walker
et al., 2010) and in animal/cellular disease models associated with
mutant FUS, TDP-43, C9orf72, optineurin, and SOD1 (Atkin
et al., 2006; Oh et al., 2008; Walker and Atkin, 2011; Farg et al.,
2012; Walker et al., 2013; Zhang et al., 2014; Sundaramoorthy
et al., 2015). Interestingly ER stress develops first in the most
vulnerable motor neurons in SOD1G93A mice, 60 days before
disease onset (Saxena et al., 2009), thus implicating ER stress as
an active mechanism inducing cell death in ALS. Similarly, Golgi
fragmentation is a prominent pathological feature in human
ALS, and appears at a similar time point in SOD1 mice models
(Gonatas et al., 1992; Mourelatos et al., 1994; van Dis et al., 2014).
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TABLE 1 | List of major ALS genes and ALS-linked proteins with established intracellular and axonal trafficking functions.
Major ALS genes Chromosome location Disease feature Percentage of ALS References
Familial Sporadic
C9ORF72 9p21 ALS, FTD, ALS with FTD 40 7 DeJesus-Hernandez et al., 2011; Renton et al.,
2011
SOD1 21q22 ALS 12 1–2 Rosen et al., 1993
TARDBP 1p36 ALS, FTD, ALS with FTD 4 1 Sreedharan et al., 2008
FUS 16p11 ALS, FTD, ALS with FTD 4 1 Kwiatkowski et al., 2009; Vance et al., 2009
ALS-linked proteins Cellular trafficking function
C9ORF72 • Possible involvement in Rab-mediated membrane trafficking processes.
• Predicted to function as a Rab guanine nucleotide exchange factor (GEF).
Zhang et al., 2012; Levine et al., 2013; Farg
et al., 2014
Optineurin • Vesicular trafficking of secretory proteins, autophagosomes and lysosomes. Sahlender et al., 2005; Tumbarello et al., 2012;
Sundaramoorthy et al., 2015
VCP • Secretory protein trafficking. Ballar et al., 2011; Arita et al., 2012; Yi et al.,
2012• Translocation of misfolded proteins from the ER to cytoplasm for proteosome
degradation.
Profilin1 • Polymerization of the actin cytoskeleton. Pantaloni and Carlier, 1993
VAPB • Vesicular ER-Golgi trafficking, dendritic membrane protein trafficking.
• Also involved in microtubule organization.
Skehel et al., 2000; Kuijpers et al., 2013
SQSTM1/p62 • Mediates AMPA receptor trafficking at the synapse and and also dynein-linked
cellular trafficking.
Jiang et al., 2009; Calderilla-Barbosa et al.,
2014
• Mediates Cargo recognition and trafficking in autophagy.
Alsin • Functions as a GEF for Rab5 and Rac1.
• Involved in in Rab5-endocytic trafficking and Rac1 regulation of the actin
cytoskeleton.
Otomo et al., 2003; Topp et al., 2004
CHMP2B • Component of endosomal sorting complex required for transport-III (ESCRT-III),
essential for endocytic trafficking.
Urwin et al., 2010
Dynactin • Mediates dynein and kinesin 2 driven intracellular and axonal trafficking on
microtubules.
Schroer, 2004; Ross et al., 2008
Neurofilament heavy chain • Essential for maintaining axon structure and function. Liu et al., 2004
TUBA4A • Component of microtubule cytoskeleton. Oakley, 2000
Peripherin • Type III neuronal intermediate filament involved in peripheral axon outgrowth
and regeneration.
Oblinger et al., 1989
Spatacsin • Involved in axonal anterograde vesicular trafficking. Pérez-Brangulí et al., 2014
Phosphoinositide 5 phosphatase • Associated with late endosome/lysosomal membrane trafficking pathways. Chow et al., 2007; Ruscher and Wieloch, 2015
Sigma-1 receptor • Involved in lipid rafts associated transport of proteins and lipids to plasma
membrane.
Pabba et al., 2014; Ruscher and Wieloch, 2015
GOLGI FRAGMENTATION IN ALS
Fragmentation of the Golgi was first identified in ALS patient
motor neurons over 20 years ago (Gonatas et al., 1992). In
contrast to control patients, the Golgi in ALS patients was
reduced and fragmented, appearing as disconnected punctate
structures, similar to its morphology in cells treated with
microtubule depolymerisation agents (Mourelatos et al., 1990;
Gonatas et al., 1992). Since then, other studies have confirmed
Golgi fragmentation in 10–50% sporadic patients (Gonatas
et al., 2006; van Dis et al., 2014) and up to 70% of
familial ALS patient motor neurons, bearing SOD1, FUS or
optineurin mutations (Fujita et al., 2008; Ito et al., 2011).
Interestingly, Golgi fragmentation is more prominent in larger
human motor neurons, such as those in the cerebral cortex
(Fujita et al., 1999) and anterior horn (Fujita et al., 2000),
suggesting they are specifically vulnerable to disturbances in
Golgi function.
Golgi fragmentation is also present in spinal anterior horn
cells in sporadic ALS patients with cytoplasmic mislocalization
of WT TDP-43, implying that a link exists between TDP-
43 and Golgi pathologies (Fujita et al., 2008). Similarly,
Golgi fragmentation is present in transgenic rats expressing
mutant TDP-43M337V (Tong et al., 2012), in mutant SOD1G93A
transgenic mice and in neuronal cells expressing SOD1G93A,G85R
mutants (Mourelatos et al., 1996; Stieber et al., 2004).
Interestingly, Golgi fragmentation precedes SOD1 inclusion
formation, neuromuscular denervation, and mitochondrial-
mediated apoptosis in low-copy number SOD1G93A transgenic
mice, implying it is upstream in pathogenesis (van Dis et al.,
2014). Similarly, ALS patients with optineurin mutations (<1%
familial cases) demonstrate Golgi fragmentation in ∼70% of
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anterior horn cells (Ito et al., 2011). Furthermore, Golgi
fragmentation is present in cells expressing ALS-linked mutant
FUS, optineurin and vesicle-associated membrane protein B
(VAPB) (Teuling et al., 2007; Farg et al., 2013; Sundaramoorthy
et al., 2015). However, despite being widely associated with
ALS, the cellular events triggering Golgi fragmentation and the
resulting consequences are not established. Increasing evidence
implicates inhibition of vesicular trafficking between the ER-
Golgi in ALS, which may explain the previous observations of
Golgi fragmentation.
IMPAIRMENT OF CELLULAR
TRAFFICKING IS A TRIGGER FOR GOLGI
FRAGMENTATION IN ALS
The ER-Golgi compartments form the first part of the cellular
secretory pathway, hence they are sensitive to alterations
in the rate of trafficking (Pelletier et al., 2000; Lee et al.,
2004), and trafficking inhibition leads to dysfunction in both
compartments. In the ER, accumulation of unfolded nascent
secretory proteins in the lumen triggers the UPR. The UPR
initially aims to reduce protein synthesis and increase protein
folding (Graves et al., 2001; Preston et al., 2009). However,
when impairment of trafficking persists, prolonged UPR results
in activation of apoptosis (Szegezdi et al., 2006; Hetz, 2012).
Similarly the organization of the Golgi depends on efficient
bidirectional vesicular transport with the ER (Nassif et al., 2010).
The formation of Golgi stacks requires continuous recycling
of Golgi proteins to/from the ER (Lippincott-Schwartz et al.,
2000). Inhibition of protein export from the ER disrupts Golgi
organization (Storrie et al., 1998), resulting in the formation
of tubulovesicular Golgi clusters, some of which fuse with the
ER (Puri and Linstedt, 2003), which can further increase ER
stress. Similarly, inhibition of vesicular trafficking from the
Golgi to plasma membrane leads to protein accumulation within
the Golgi. If prolonged, this can fragment the Golgi (Persson
et al., 1992; Zolov and Lupashin, 2005; Zhou et al., 2013).
Approximately one-third of the human proteome transverses
through the Golgi destined for transmembrane, synaptic, axonal,
or extracellular locations (Braakman and Bulleid, 2011). Hence
disruption to intracellular trafficking involving the Golgi could
severely compromise neuronal function and viability.
We recently demonstrated that Golgi-associated vesicular
trafficking is inhibited in cells expressing ALS-mutant proteins:
SOD1, FUS, TDP-43, and optineurin, providing an intriguing
mechanism explaining Golgi fragmentation in patient tissues
(Sundaramoorthy et al., 2013, 2015; Atkin et al., 2014; Soo
et al., 2015a). Furthermore, inhibition of ER-Golgi transport by
mutant SOD1 preceded all other cellular pathologies examined
in neuronal cells, including ER stress, Golgi fragmentation,
protein aggregation, inclusion formation, and apoptosis (Atkin
et al., 2014). This implies that ER-Golgi trafficking defects may
trigger ER-Golgi pathology in SOD1-ALS cases.More recently we
demonstrated that mutant forms of both FUS and TDP-43 impair
the incorporation of secretory cargo into COPII vesicles budding
off from the ER, impeding protein export from the ER, while
mutant SOD1 was shown to inhibit ERGIC-Golgi trafficking by
destabilizing microtubules (Soo et al., 2015a). Furthermore, we
have also demonstrated that misfolded WT SOD1 also impairs
ER-Golgi trafficking similar to mutant SOD1, resulting in ER
stress and Golgi fragmentation (Sundaramoorthy et al., 2015),
although it remains controversial whether misfolded WT SOD1
is present in sporadic ALS tissues (Liu et al., 2009; Forsberg
et al., 2010; Grad et al., 2014). However, it is tempting to
speculate that impairment of ER-Golgi trafficking is a common
trigger for Golgi fragmentation in sporadic and familial ALS.
Similarly, we have also shown that expression of ALS-optineurin
mutants impair myosin VI-mediated protein trafficking from the
Golgi to plasma membrane, also inducing Golgi fragmentation
(Sundaramoorthy et al., 2015). Hence these results imply that
impairment of distinct protein trafficking pathways by different
ALS-linked proteins are specific triggers for Golgi fragmentation
in ALS (Figure 1).
Consistent with this notion, mutations in genes encoding
proteins directly involved in intracellular trafficking are present
in familial ALS (Table 1). Firstly, mutations in the gene encoding
the p150Glued subunit of the dynein/dynactin complex were
reported in sporadic and familial ALS (Münch et al., 2004).
The ALS causing mutation impedes binding of p150Glued
to microtubules, resulting in dysfunctional dynein/dynactin-
mediated transport (Levy et al., 2006). Similarly, mutations in
proteins directly involved in the ER-Golgi secretory pathway,
including VAPB and VCP, are present in ALS (Nishimura et al.,
2004; Johnson et al., 2010; Yi et al., 2012; Kuijpers et al., 2013).
Recent findings ofmutations in ALS-associated genes that encode
cytoskeletal associated proteins provide additional evidence for
trafficking disruption in ALS. Mutations in profilin 1, which
mediates the conversion of soluble G-actin to functional F-
actin, (Wu et al., 2012), and in tubulin alpha 4A (TUBA4A), a
component of microtubules, were recently reported in familial
ALS (Smith et al., 2014).
The identification of hexanucleotide (GGGGCC) repeat
expansion mutations in C9ORF72 as the major cause of
familial ALS and FTD (40%), further links cellular trafficking
to ALS. Whilst the normal cellular function of C9orf72
was initially unknown, bioinformatics studies first predicted
that C9orf72 functions in Rab-mediated trafficking (Zhang
et al., 2012; Levine et al., 2013). Rab proteins form a large
family of small guanosine triphosphate (GTP)ases that regulate
vesicular trafficking at distinct cellular membranes (Stenmark
and Olkkonen, 2001). Rab proteins are activated by conversion
from an inactive guanosine diphosphate (GDP)-bound state
to an active GTP-bound form, which is catalyzed by guanine
nucleotide exchange factors (GEFs) (Stenmark and Olkkonen,
2001; Cherfils and Zeghouf, 2013). Bioinformatics predicted that
C9orf72 functions as a RabGEF, because of the strong sequence
and structural similarity to other evolutionary conserved
differentially expressed in normal and neoplastic cells (DENN)
domain-containing RabGEFs (Zhang et al., 2012; Levine et al.,
2013). Consistent with these predictions, we demonstrated that
C9orf72 associates with multiple Rabs including Rab1, which
mediates ER-Golgi transport (Farg et al., 2014). Furthermore,
we also found that depletion of C9orf72 using siRNA impaired
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autophagy and endocytic trafficking from the plasma membrane
to Golgi (Farg et al., 2014). Whilst the hexanucleotide repeat
expansion is present within an intronic region of C9ORF72,
expression of C9orf72 protein is reduced in ALS patients
causing haploinsufficiency (DeJesus-Hernandez et al., 2011;
Haeusler et al., 2014). Hence this would disrupt the normal
trafficking function of C9orf72 in ALS. However, recent studies
have argued against this mechanism of pathogenesis (Koppers
et al., 2015). Nevertheless, we also demonstrated increased
association of C9orf72 with Rab7 and Rab11 in C9orf72-ALS
patients, implying that intracellular trafficking is dysregulated
in C9orf72-ALS, although the mechanism remains unclear
(Farg et al., 2014). However, further studies are required to
examine the relationship between C9orf72 and trafficking defects,




The initial step in autophagy is the formation of a double-
membraned phagophore, which then expands in size, engulfing
defective proteins, damaged cellular organelles, or pathogens,
forming the autophagosome (Reggiori and Klionsky, 2005).
Although the membranes forming the autophagosome originate
from multiple cellular organelles, the ER is implicated as
the primary source of membrane because the omegasome,
the autophagosome precursor, originates from ER cisternae
(Hayashi-Nishino et al., 2009). However, the Golgi is necessary
for subsequent autophagosome elongation, and Golgi-mediated
trafficking provides membrane components for autophagosome
biogenesis. Beclin1, which is located in the trans-Golgi network,
recruits other autophagy-related (Atg) proteins for assembly
into the autophagosome, (Kihara et al., 2001) and Atg9-
positive vesicles cycle from the Golgi to deliver membranes
to the developing autophagosome (Young et al., 2006; Webber
et al., 2007). Blocking ER to cis-Golgi transport, or transport
from the trans-Golgi to plasma membrane/endosomes, reduces
autophagosome formation in mammalian cells (Zoppino et al.,
2010; Guo et al., 2012). Furthermore, the Golgi recognizes
and sorts lysosomal enzymes, which are then packaged into
vesicles that bud from the trans-Golgi, forming lysosomes
(Griffiths et al., 1988; Kornfeld and Mellman, 1989; Riederer
et al., 1994). Hence these observations imply that disruption
of Golgi-associated trafficking may impair autophagosome
formation.
In contrast, fragmentation of the Golgi has also been
shown to increase autophagosome biogenesis by feeding
Atg9-positive fragmented Golgi membranes during starvation-
induced autophagy (Takahashi et al., 2011). Pharmacological
induction of Golgi fragmentation with Brefeldin A or Golgicide
increases autophagosome biogenesis and induces accumulation
of autophagosomes (Naydenov et al., 2012), but it can also block
autophagosome formation in some cases (Nishida et al., 2009).
Observations of Golgi fragmentation and autophagy dysfunction
imply a possible link between these two pathologies in ALS.
Hence examination of the pathological relationship between
Golgi fragmentation and autophagy in ALS is warranted.
GOLGI FRAGMENTATION AND AXONAL
HOMEOSTASIS
Motor neurons differ from other neurons in that they are
exceptionally large, with long axons, up to 1m in length in
an adult human. These distal axons require membrane and
cytoskeletal proteins, neurotransmitter receptors, and lipids
to maintain synaptic plasticity, synaptogenesis, excitability,
dendritic, and neurite outgrowth (Horton and Ehlers, 2004; Tuck
and Cavalli, 2010; Ori-McKenney et al., 2012). These components
must be transported from the ER/Golgi in the cell body over long
distances along the axon. In addition to this traditional route,
proteins are also synthesized via axonal ribosomes (Koenig et al.,
2000; Kun et al., 2007) and mRNA (Taylor et al., 2009; Jung
et al., 2012), thus facilitating local protein synthesis. Proteins
synthesized in neurites are processed and secreted via Golgi
outposts (Horton and Ehlers, 2003; Merianda et al., 2009)
(Figure 1). These Golgi outposts share similar molecular markers
to the somatic Golgi (Gardiol et al., 1999; Horton and Ehlers,
2003) and they handle secretion of essential axonal/dendritic
membrane proteins (Lu et al., 2001; Passafaro et al., 2001).
Similarly, cytoskeletal proteins processed via Golgi outposts
are essential for axonal regeneration and plasticity of dendritic
spines (Matus, 2000; Gu et al., 2008; Tuck and Cavalli, 2010;
Shirao and González−Billault, 2013). Fragmentation of the
neuronal Golgi would therefore be expected to impair normal
axonal functions. In support of this notion, induction of Golgi
fragmentation with Brefeldin A reduces synaptic potentiation
and AMPA receptor expression on the postsynaptic membrane
(Broutman and Baudry, 2001), and reduces axonal outgrowth
(Jareb and Banker, 1997). Interestingly, fragmentation of somatic
and dendritic Golgi inmotor neurons accompanied by trafficking
defects, preceded axonal retraction and muscle denervation in
mice models of ALS (van Dis et al., 2014). Therefore, Golgi
fragmentation may be an important trigger for loss of axonal
homeostasis and degeneration of motor neurons in ALS.
CONCLUSION
An emerging concept in ALS is that the diverse mechanisms
implicated in pathology are inter-linked, and that disturbances
in one pathway induce other pathogenic mechanisms,
resulting in neurodegeneration. Increasing evidence links Golgi
fragmentation to recent pathological mechanisms implicated
in ALS, including disruption of intracellular trafficking and ER
stress. This warrants future studies examining the relationship
between Golgi fragmentation to other somatic Golgi functions,
including autophagy, and specific neuronal functions of the
Golgi, such as axonal homeostasis (Figure 1). The unique
characteristics of neurons and the existence of Golgi outposts
may confer additional, more specialized functions of the Golgi
in these cells which may render these cells more vulnerable to
neurodegeneration in ALS.
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